ATXS vs IRM · rev $706.0K vs P/E 136, rev $3.97B
Astria Therapeutics Inc (ATXS) versus Iron Mountain Incorporated (IRM) — a side-by-side from cached financials, not a winner call.
Astria Therapeutics Inc (ATXS) is a biotechnology company listed on US.
Iron Mountain Incorporated (IRM) is a reit - specialty company listed on US.
Latest reported ATXS revenue for 2025-09-30 was $706.0K. Net income was -$98.4M. ATXS currently screens at market cap $382.1M.
Latest reported IRM revenue for 2026-06-30 was $3.97B. Net income was $255.1M. IRM currently screens at market cap $37.09B and trailing P/E 135.5.
ATXS currently screens at market cap $382.1M. IRM currently screens at market cap $37.09B and trailing P/E 135.5.
Not investment advice. Open the ATXS and IRM stock pages for the full models.
Not investment advice.